
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-08-05-2015
- Volume 11
- Issue 8
BioOutsource Opens New Facility in Glasgow
The investment doubles the company’s capacity to meet increasing demand for its biologics contract testing and biosimilar characterization services.
BioOutsource, part of Sartorius Stedim Biotech Group, has opened a new facility in Glasgow. The investment follows the increasing demand for the company’s biologics contract testing and biosimilar characterization services. The new facility doubles BioOutsource’s capacity for future growth and will create approximately 50 new jobs for scientific and technical professionals in the next six months, according to the company.
Source:
Articles in this issue
about 11 years ago
CDMOs Move Slowly with Expansion Plansabout 11 years ago
Accelerating Continuous API Synthesisabout 11 years ago
Silicone Rubber Pieces Spur Recall of Teva Productabout 11 years ago
Baxter Recalls IV Solution for Container and Particulate Issuesabout 11 years ago
Indian API Manufacturer Cited for Recordkeeping Failuresabout 11 years ago
Xcelience Makes Investment in Powdersizeabout 11 years ago
FDA Issues Quality Metrics Draft Guidance Document for Commentabout 11 years ago
EMA Issues Guideline on Fast Tracking Drugs for Unmet Needsabout 11 years ago
SafeBridge Updates Potent API and Drug Manufacturer Status



